| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1061 | 2020 |
| Analyses of non-coding somatic drivers in 2,658 cancer whole genomes E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ... Nature 578 (7793), 102-111, 2020 | 371 | 2020 |
| Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer AW Wyatt, F Mo, K Wang, B McConeghy, S Brahmbhatt, L Jong, ... Genome biology 15 (8), 1-14, 2014 | 91 | 2014 |
| BAP1 Haploinsufficiency Predicts a Distinct Immunogenic Class of Malignant Peritoneal Mesothelioma R Shrestha, N Nabavi, YY Lin, F Mo, S Anderson, S Volik, HH Adomat, ... Genome Medicine 11 (1), 8, 2019 | 77 | 2019 |
| Pathway and network analysis of more than 2500 whole cancer genomes MA Reyna, D Haan, M Paczkowska, LPC Verbeke, M Vazquez, ... Nature communications 11 (1), 729, 2020 | 67 | 2020 |
| Ultra high-dimensional nonlinear feature selection for big biological data M Yamada, J Tang, J Lugo-Martinez, E Hodzic, R Shrestha, H Ouyang, ... IEEE Transactions on Knowledge and Data Engineering, 2018 | 63 | 2018 |
| HIT'nDRIVE: Patient-specific multi-driver gene prioritization for precision oncology R Shrestha, E Hodzic, T Sauerwald, P Dao, K Wang, J Yeung, ... Genome Research, 2017 | 40 | 2017 |
| High-throughput detection of RNA processing in bacteria EE Gill, LS Chan, GL Winsor, N Dobson, R Lo, SJ Ho Sui, BK Dhillon, ... BMC genomics 19 (1), 1-20, 2018 | 32 | 2018 |
| BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate CancerBIRC6 as a Target for Enzalutamide-Resistant CRPC ISU Luk, R Shrestha, H Xue, Y Wang, F Zhang, D Lin, A Haegert, R Wu, ... Clinical Cancer Research 23 (6), 1542-1551, 2017 | 29 | 2017 |
| Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma NM D’Costa, MR Lowerison, PA Raven, Z Tan, ME Roberts, R Shrestha, ... Journal of Experimental & Clinical Cancer Research 39, 1-16, 2020 | 17 | 2020 |
| Identification of gene signature for treatment response to guide precision oncology in clear-cell renal cell carcinoma NM D’Costa, D Cina, R Shrestha, RH Bell, YY Lin, H Asghari, ... Scientific Reports 10 (1), 2026, 2020 | 14 | 2020 |
| An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer R Das, M Sjöström, R Shrestha, C Yogodzinski, EA Egusa, LN Chesner, ... Nature Communications 12 (1), 4601, 2021 | 13 | 2021 |
| Well-Differentiated Papillary Mesothelioma of the Peritoneum is Genetically Distinct from Malignant Mesothelioma R Shrestha, N Nabavi, S Volik, S Anderson, A Haegert, B McConeghy, ... Cancers 12 (6), 2020 | 13 | 2020 |
| HIT’nDRIVE: Multi-Driver Gene Prioritization based on Hitting Time R Shrestha, E Hodzic, J Yeung, K Wang, T Sauerwald, P Dao, ... | 13 | 2014 |
| Deep genomic signature for early metastasis prediction in prostate cancer H Sharifi-Noghabi, Y Liu, N Erho, R Shrestha, M Alshalalfa, E Davicioni, ... BioRxiv, 276055, 2018 | 12 | 2018 |
| A meta-analysis approach for characterizing pan-cancer mechanisms of drug sensitivity in cell lines K Wang, R Shrestha, AW Wyatt, A Reddy, J Lehár, Y Wang, A Lapuk, ... PLoS One 9 (7), e103050, 2014 | 11 | 2014 |
| Multiomics characterization of low-grade serous ovarian carcinoma identifies potential biomarkers of MEK inhibitor sensitivity and therapeutic vulnerability R Shrestha, ML Fernandez, A Dawson, J Hoenisch, S Volik, YY Lin, ... Cancer Research, 2021 | 10 | 2021 |
| Autoantibody Landscape in Patients with Advanced Prostate CancerAutoantibody Landscape of Advanced Prostate Cancer WS Chen, WA Haynes, R Waitz, K Kamath, A Vega-Crespo, R Shrestha, ... Clinical Cancer Research 26 (23), 6204-6214, 2020 | 9 | 2020 |
| Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks E Hodzic, R Shrestha, K Zhu, K Cheng, CC Collins, SC Sahinalp GigaScience 8 (4), 369850, 2019 | 9 | 2019 |
| Predicting cancer drug TARGETS-treatment response generalized elastic-neT signatures NR Rydzewski, E Peterson, JM Lang, M Yu, S Laura Chang, M Sjöström, ... NPJ genomic medicine 6 (1), 76, 2021 | 8 | 2021 |
Colin Collins, PhDProfessor of Urologic Sciences, University of British Columbia and Vancouver Prostate CentreVerified email at prostatecentre.com
